Imaging treated prostate cancer - Abstract

In patients with a clinical suspicion of recurrence after treatment for prostate cancer, imaging can be used to distinguish between local recurrence and metastatic disease.

Multiparametric magnetic resonance imaging (mpMRI) of the prostate may be a valuable imaging modality for the detection and localization of local recurrence in patients treated for prostate cancer. In mpMRI, morphological T2-weighted images are combined with functional MRI techniques including diffusion-weighted imaging, dynamic contrast-enhanced imaging, and magnetic resonance spectroscopic imaging to improve accuracy. In this paper, the current status of imaging techniques used to detect and to localize tumor recurrence in patients treated for prostate cancer will be reviewed, with emphasis on mpMRI for local prostate cancer recurrence.

Written by:
De Visschere PJ, Vargas HA, Ost P, De Meerleer GO, Villeirs GM.   Are you the author?
Department of Radiology, Ghent University Hospital, De Pintelaan 185, 9000, Ghent, Belgium.

Reference: Abdom Imaging. 2013 Apr 20. Epub ahead of print.
doi: 10.1007/s00261-013-9998-3


PubMed Abstract
PMID: 23604966

UroToday.com Prostate Cancer Section

 

 

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe